Takanobu Motoshima

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study.

Masaki Shiota, Shota Nemoto, Ryo Ikegami

|Dec 27, 2024
ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma.

Jinglong Tang, Shintaro Funasaki, Hidekazu Nishizawa

|Mar 06, 2023
Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma.

Takuya Segawa, Takanobu Motoshima, Junji Yatsuda

|Sep 12, 2022
Clear cell carcinoma of the seminal vesicle in a young adult.

Hidetoshi Murakami, Takanobu Motoshima, Ryoma Kurahashi

|Jul 07, 2022
Subcapsular renal hematoma after ureterorenoscopy.

Narumi Harada, Junji Yatsuda, Ryoma Kurahashi

Pageof 1

Frequent Collaborators

3 joint publications

Junji Yatsuda

1 joint publications

Narumi Harada

1 joint publications

Takuya Segawa

1 joint publications

Jinglong Tang